603127.SH
昭衍新药
SSE · Healthcare · Medical - Diagnostics & Research · CN
CNY 46.39
−5.85%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 38.87x
- P/E 2027E
- 59.43x
- P/E 2028E
- 34.91x
- P/S forward
- 41.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 116.71x
- PEG TTM
- —
- Price / book
- 4.11x
- Price / sales
- 19.08x
- Price / cash flow
- 63.46x
Enterprise value
- Enterprise value
- CNY 31.2B
- EV / sales
- 18.50x
- EV / EBITDA
- 66.46x
- EV / EBIT
- 57.31x
- Market cap
- CNY 34.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026